The Growing Self-Testing Market is driven by Rising Prevalence of Chronic Diseases
The self-testing market involves products that enable individuals to collect and test their own specimens such as blood, urine, or saliva, at home and receive diagnosis for various health conditions. This includes products for testing diseases such as diabetes, cardiac disorders, pregnancy, HIV/AIDS, and drugs of abuse. Self-testing products offer advantages such as convenience, time-saving, low-cost, and privacy compared to lab tests. The growing prevalence of various chronic and infectious diseases globally is increasing the demand for self-monitoring and diagnosis outside of clinical settings.
The Global Self-Testing Market is estimated to be valued at US$ 25191.62 Mn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 To 2031.
The demand for Self-Testing Market Size is increasing rapidly mainly due to the rising prevalence of chronic diseases globally and growing awareness about disease diagnosis and management. Self-testing helps detect diseases early and allows timely treatment interventions.
Key Takeaways
Key players operating in the self-testing market are BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others. These players are focusing on developing easy-to-use self-testing kits and strengthening their online service offerings to cater to the growing demand.
The self-testing market is also expanding globally with companies focusing on markets in Asia Pacific and Latin America. The increasing healthcare expenditure and expanding medical insurance coverage in developing economies will further drive the adoption of self-testing products in the coming years.
Get More Insights On Self-Testing Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian